CA
NZ
UK
AU
IND
US
Brown-Forman Corporation (NYSE:BF.B) shares traded sharply higher Monday after the company disclosed that its Board of Directors had received and rejected an unsolicited proposal from Sazerac to acquire the company, concluding that the offer was not actionable after taking into account the views of …
Rivian Automotive, Inc. (NASDAQ:RIVN) shares advanced sharply Monday after Piper Sandler upgraded the stock to Overweight from Neutral and raised its price target to $20 from $18, citing improving fundamentals ahead of the company's July 30 earnings report.
Rigetti Computing, Inc. (NASDAQ:RGTI) shares rallied Monday after the company announced it will partner with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center to build the TangleLab supercomputing testbed, funded by a $5 million National Science Foundation grant.
D-Wave Quantum Inc. (NYSE:QBTS) shares surged Monday after the company announced that AT&T has signed an agreement to expand its use of D-Wave's quantum computing technology to address complex optimization challenges across its network operations.
MapLight Therapeutics, Inc. (NASDAQ:MPLT) shares collapsed in Monday trading, even as the company characterized topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA in schizophrenia as positive. The sharp decline reflects a market interpretation that diverged significantly from the company's own framing of …
AT&T Inc. (NYSE:T) shares traded modestly higher Monday, extending last week's historic surge following a strong second-quarter earnings report. The stock's gains continued as the company announced an expanded quantum computing partnership with D-Wave Quantum aimed at optimizing network operations.
SAP SE (NYSE:SAP) shares surged Monday, extending a powerful rebound that began late last week as the German software giant's strong quarterly results and a newly activated stock buyback program continued to reshape investor sentiment. The stock had touched a 52-week low just days …
Johnson & Johnson reports oncology revenue climbing at high‑teen rates, targeting at least $50 billion in cancer drug sales by 2030 and projecting just over $100 billion in total revenue this year. The surge bolsters its dividend‑king profile, making the stock appealing for income …
GXO Logistics reported earnings per share of $0.50 for the quarter ending March 31, exceeding estimates of $0.37. The strong performance underscores its strategic focus on the growing healthcare sector’s logistics needs, especially in cold storage for medications like GLP-1s.[CTA: Subscribe to our healthcare …
Lisata Therapeutics (NASDAQ: LSTA) has terminated its pending merger after the buyer could not fund the $4.00 per share offer, triggering a $2,000,000 termination fee. Investors face heightened uncertainty as the company now must consider alternatives, potentially affecting share value amid a 51.5% one‑month …
Please wait processing your request...